0.012341
0.007125
0.000000
0.000000
0.014250
0.000000
0.000000
0.000000
0.029499
0.00000
0.00000
0.00000
Wagner, A.
Diez, J.
Schulze-Briese, C.
Schluckebier, G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
18
90.00
90.00
120.00
81.030
81.030
33.900
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C8 H8 O3
152.147
4-HYDROXY-BENZOIC ACID METHYL ESTER
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Zn 2
65.409
ZINC ION
non-polymer
US
Proteins
PSFGEY
0867
0887-3585
74
1018
10.1002/PROT.22213
18767151
Crystal Structure of Ultralente--A Microcrystalline Insulin Suspension.
2009
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
MICRO FOCUS
CCD
MARRESEARCH
SINGLE WAVELENGTH
M
x-ray
1
0.9786
1.0
X06SA
SLS
0.9786
SYNCHROTRON
SLS BEAMLINE X06SA
ULTRALENTE INSULIN CRYSTALS
2383.698
INSULIN A CHAIN
RESIDUES 90-110
2
man
polymer
ULTRALENTE INSULIN CRYSTALS
3433.953
INSULIN B CHAIN
RESIDUES 25-54
2
man
polymer
65.409
ZINC ION
4
syn
non-polymer
152.147
4-HYDROXY-BENZOIC ACID METHYL ESTER
1
syn
non-polymer
18.015
water
66
nat
water
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A,C
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
B,D
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
4932
SACCHAROMYCES CEREVISIAE
HUMAN
sample
9606
HOMO SAPIENS
4932
SACCHAROMYCES CEREVISIAE
1
1.78
30.48
DATA COLLECTION FROM MICRO CRYSTAL 25-X-25 X 8 MICROMETER
5.5
pH 5.5
repository
Initial release
Advisory
Version format compliance
Database references
Derived calculations
Other
1
0
2008-09-16
1
1
2011-07-13
1
2
2011-08-03
R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES
INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER
STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER
1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES)
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES)
NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)
CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN
INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES
INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES
CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY.
SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN)
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D;
T6 HUMAN INSULIN AT 1.0 A RESOLUTION
DEHYDRATED T6 HUMAN INSULIN AT 295 K
CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT.
STRUCTURE OF INSULIN
INSULIN, MONOCLINIC CRYSTAL FORM
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES
HUMAN INSULIN MUTANT SERB9GLU
AN ACTIVE MINI-PROINSULIN, M2PI
THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION.
INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES)
INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES
NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
LYS(B28)PRO(B29)-HUMAN INSULIN
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)];
DEHYDRATED T6 HUMAN INSULIN AT 100 K
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES
NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES
MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES
SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2)
NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS
INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA
STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
STRUCTURE OF INSULIN
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE
INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
PDBE
Y
PDBE
2007-12-14
REL
ZN
ZINC ION
MPB
4-HYDROXY-BENZOIC ACID METHYL ESTER
HOH
water
ZN
1031
3
ZN
ZN
1031
B
MPB
1022
4
MPB
MPB
1022
C
ZN
1030
3
ZN
ZN
1030
D
ZN
1031
3
ZN
ZN
1031
D
ZN
1032
3
ZN
ZN
1032
D
HOH
2001
5
HOH
HOH
2001
A
HOH
2002
5
HOH
HOH
2002
A
HOH
2003
5
HOH
HOH
2003
A
HOH
2004
5
HOH
HOH
2004
A
HOH
2005
5
HOH
HOH
2005
A
HOH
2006
5
HOH
HOH
2006
A
HOH
2007
5
HOH
HOH
2007
A
HOH
2008
5
HOH
HOH
2008
A
HOH
2009
5
HOH
HOH
2009
A
HOH
2010
5
HOH
HOH
2010
A
HOH
2011
5
HOH
HOH
2011
A
HOH
2012
5
HOH
HOH
2012
A
HOH
2013
5
HOH
HOH
2013
A
HOH
2014
5
HOH
HOH
2014
A
HOH
2015
5
HOH
HOH
2015
A
HOH
2001
5
HOH
HOH
2001
B
HOH
2002
5
HOH
HOH
2002
B
HOH
2003
5
HOH
HOH
2003
B
HOH
2004
5
HOH
HOH
2004
B
HOH
2005
5
HOH
HOH
2005
B
HOH
2006
5
HOH
HOH
2006
B
HOH
2007
5
HOH
HOH
2007
B
HOH
2008
5
HOH
HOH
2008
B
HOH
2009
5
HOH
HOH
2009
B
HOH
2010
5
HOH
HOH
2010
B
HOH
2011
5
HOH
HOH
2011
B
HOH
2012
5
HOH
HOH
2012
B
HOH
2013
5
HOH
HOH
2013
B
HOH
2014
5
HOH
HOH
2014
B
HOH
2015
5
HOH
HOH
2015
B
HOH
2016
5
HOH
HOH
2016
B
HOH
2017
5
HOH
HOH
2017
B
HOH
2018
5
HOH
HOH
2018
B
HOH
2019
5
HOH
HOH
2019
B
HOH
2020
5
HOH
HOH
2020
B
HOH
2021
5
HOH
HOH
2021
B
HOH
2022
5
HOH
HOH
2022
B
HOH
2023
5
HOH
HOH
2023
B
HOH
2024
5
HOH
HOH
2024
B
HOH
2025
5
HOH
HOH
2025
B
HOH
2001
5
HOH
HOH
2001
C
HOH
2002
5
HOH
HOH
2002
C
HOH
2003
5
HOH
HOH
2003
C
HOH
2004
5
HOH
HOH
2004
C
HOH
2005
5
HOH
HOH
2005
C
HOH
2006
5
HOH
HOH
2006
C
HOH
2007
5
HOH
HOH
2007
C
HOH
2008
5
HOH
HOH
2008
C
HOH
2009
5
HOH
HOH
2009
C
HOH
2001
5
HOH
HOH
2001
D
HOH
2002
5
HOH
HOH
2002
D
HOH
2003
5
HOH
HOH
2003
D
HOH
2004
5
HOH
HOH
2004
D
HOH
2005
5
HOH
HOH
2005
D
HOH
2006
5
HOH
HOH
2006
D
HOH
2007
5
HOH
HOH
2007
D
HOH
2008
5
HOH
HOH
2008
D
HOH
2009
5
HOH
HOH
2009
D
HOH
2010
5
HOH
HOH
2010
D
HOH
2011
5
HOH
HOH
2011
D
HOH
2012
5
HOH
HOH
2012
D
HOH
2013
5
HOH
HOH
2013
D
HOH
2014
5
HOH
HOH
2014
D
HOH
2015
5
HOH
HOH
2015
D
HOH
2016
5
HOH
HOH
2016
D
HOH
2017
5
HOH
HOH
2017
D
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
n
1
1
B
n
2
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
GLY
1
n
1
GLY
1
C
ILE
2
n
2
ILE
2
C
VAL
3
n
3
VAL
3
C
GLU
4
n
4
GLU
4
C
GLN
5
n
5
GLN
5
C
CYS
6
n
6
CYS
6
C
CYS
7
n
7
CYS
7
C
THR
8
n
8
THR
8
C
SER
9
n
9
SER
9
C
ILE
10
n
10
ILE
10
C
CYS
11
n
11
CYS
11
C
SER
12
n
12
SER
12
C
LEU
13
n
13
LEU
13
C
TYR
14
n
14
TYR
14
C
GLN
15
n
15
GLN
15
C
LEU
16
n
16
LEU
16
C
GLU
17
n
17
GLU
17
C
ASN
18
n
18
ASN
18
C
TYR
19
n
19
TYR
19
C
CYS
20
n
20
CYS
20
C
ASN
21
n
21
ASN
21
C
n
1
1
D
n
2
2
D
ASN
3
n
3
ASN
3
D
GLN
4
n
4
GLN
4
D
HIS
5
n
5
HIS
5
D
LEU
6
n
6
LEU
6
D
CYS
7
n
7
CYS
7
D
GLY
8
n
8
GLY
8
D
SER
9
n
9
SER
9
D
HIS
10
n
10
HIS
10
D
LEU
11
n
11
LEU
11
D
VAL
12
n
12
VAL
12
D
GLU
13
n
13
GLU
13
D
ALA
14
n
14
ALA
14
D
LEU
15
n
15
LEU
15
D
TYR
16
n
16
TYR
16
D
LEU
17
n
17
LEU
17
D
VAL
18
n
18
VAL
18
D
CYS
19
n
19
CYS
19
D
GLY
20
n
20
GLY
20
D
GLU
21
n
21
GLU
21
D
ARG
22
n
22
ARG
22
D
GLY
23
n
23
GLY
23
D
PHE
24
n
24
PHE
24
D
PHE
25
n
25
PHE
25
D
TYR
26
n
26
TYR
26
D
THR
27
n
27
THR
27
D
PRO
28
n
28
PRO
28
D
LYS
29
n
29
LYS
29
D
n
30
30
D
3.3724
-2.7982
1.4970
25.0566
-4.5299
6.8672
0.3050
-0.1631
0.2121
1.9059
-0.4780
0.7190
0.2207
-0.0797
0.1731
0.0522
-0.0289
0.0969
0.1002
-0.0699
-0.0243
refined
-17.5527
3.2261
7.1512
X-RAY DIFFRACTION
6.5864
-1.7917
1.0440
14.7851
-0.8415
7.5693
-0.0384
-0.2890
0.0013
0.7324
-0.0442
-0.4818
-0.0390
-0.5311
0.0825
-0.0142
0.0016
0.0170
-0.1000
0.0266
-0.0106
refined
-12.2215
5.5002
2.1411
X-RAY DIFFRACTION
13.1219
-0.2588
-1.3341
2.3696
1.2019
3.4586
-0.2833
1.0346
-0.2392
-0.7944
0.2331
0.5489
-0.1054
-0.4397
0.0502
0.2819
-0.0760
-0.0230
0.0235
0.0557
0.0391
refined
-3.4775
16.7617
-9.1115
X-RAY DIFFRACTION
10.3195
-0.9008
0.9903
6.9885
2.4961
5.6334
0.0413
0.4760
0.0896
-0.4038
0.0393
0.0799
-0.1596
-0.1436
-0.0805
-0.0097
-0.0237
0.0485
-0.0864
0.0612
-0.0645
refined
-5.3243
11.0453
-4.3057
X-RAY DIFFRACTION
A
1
A
21
X-RAY DIFFRACTION
1
B
1
B
30
X-RAY DIFFRACTION
2
C
1
C
21
X-RAY DIFFRACTION
3
D
1
D
30
X-RAY DIFFRACTION
4
author_and_software_defined_assembly
PISA
12
dodecameric
18950
-568.0
12600
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
1_555
113.0
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
3_555
113.0
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
3_555
113.0
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
1_555
105.6
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
1_555
105.6
B
HIS
10
B
NE2
HIS
10
3_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
1_555
105.6
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
2_555
105.6
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
2_555
105.6
B
HIS
10
B
NE2
HIS
10
3_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
2_555
105.6
B
HOH
2025
K
O
HOH
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
2_555
0.0
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
105.6
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
105.6
B
HIS
10
B
NE2
HIS
10
3_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
105.6
B
HOH
2025
K
O
HOH
1_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
0.0
B
HOH
2025
K
O
HOH
2_555
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
0.0
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
2_555
108.4
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
3_555
108.4
D
HIS
10
D
NE2
HIS
10
2_555
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
3_555
108.4
D
GLU
13
D
OE1
GLU
13
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HOH
2017
M
O
HOH
1_555
96.6
D
GLU
13
D
OE1
GLU
13
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HOH
2016
M
O
HOH
1_555
87.2
D
HOH
2017
M
O
HOH
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HOH
2016
M
O
HOH
1_555
135.4
D
GLU
13
D
OE1
GLU
13
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HIS
10
D
ND1
HIS
10
1_555
116.0
D
HOH
2017
M
O
HOH
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HIS
10
D
ND1
HIS
10
1_555
121.2
D
HOH
2016
M
O
HOH
1_555
D
ZN
1031
H
ZN
ZN
1_555
D
HIS
10
D
ND1
HIS
10
1_555
95.8
D
HOH
2017
M
O
HOH
1_555
D
ZN
1032
I
ZN
ZN
1_555
D
GLU
13
D
OE2
GLU
13
1_555
117.4
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_555
-y,x-y,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
0.8660254038
0.0000000000
-0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
3_555
-x+y,-x,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
B
N
TYR
26
B
N
TYR
26
D
O
PHE
24
D
O
PHE
24
1
B
ZN
1031
E
ZN
1
D
ZN
1030
G
ZN
1
B
HOH
2025
K
HOH
1
D
HOH
2003
M
HOH
1
B
PHE
1
B
PHE
1
1
Y
1
B
VAL
2
B
VAL
2
1
Y
1
D
PHE
1
D
PHE
1
1
Y
1
D
VAL
2
D
VAL
2
1
Y
1
D
THR
30
D
THR
30
1
Y
1
C
SER
9
-142.23
-159.83
1
D
GLN
4
-136.78
-131.54
1
D
HIS
5
-127.23
-107.40
18.75
0.08000
0.04000
0.00000
0.08000
0.00000
-0.13000
0.908
0.865
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
0.282
0.240
0.242
2.20
40.52
209
3958
5.000
98.8
19.805
0.267
RANDOM
LIKELY RESIDUAL
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.653
0.293
0.80
0.80
1.20
PDB ENTRY MSO
MAXIMUM LIKELIHOOD
MASK
2.20
40.52
66
847
15
0
766
0.006
0.021
805
0.004
0.020
520
0.970
1.985
1087
1.034
3.019
1248
5.350
5.000
91
37.341
24.865
37
17.823
15.000
124
8.774
15.000
2
0.317
0.200
115
0.002
0.020
888
0.001
0.020
166
0.158
0.200
207
0.176
0.200
525
0.181
0.200
381
0.086
0.200
399
0.106
0.200
34
0.147
0.200
20
0.092
0.200
15
0.066
0.200
7
0.164
1.500
631
0.189
2.000
764
0.272
3.000
419
0.373
4.500
323
0.3700
0.3160
2.26
15
300
20
2.20
24.10
2VK0
13231
0.0
0.07
1
11.80
3.3
98.8
0.21
2.20
2.30
5.70
1
3.2
98.7
refinement
REFMAC
5.3.0040
data reduction
XDS
data scaling
XSCALE
phasing
AMoRE
INSULIN A CHAIN, INSULIN B CHAIN
Crystal structure form ultalente insulin microcrystals
1
N
N
2
N
N
1
N
N
2
N
N
3
N
N
4
N
N
3
N
N
3
N
N
3
N
N
5
N
N
5
N
N
5
N
N
5
N
N
A
GLY
1
A
GLY
1
HELX_P
A
CYS
7
A
CYS
7
1
1
7
A
SER
12
A
SER
12
HELX_P
A
GLU
17
A
GLU
17
1
2
6
B
CYS
7
B
CYS
7
HELX_P
B
GLY
20
B
GLY
20
1
3
14
B
GLU
21
B
GLU
21
HELX_P
B
GLY
23
B
GLY
23
5
4
3
C
GLY
1
C
GLY
1
HELX_P
C
SER
9
C
SER
9
1
5
9
C
SER
12
C
SER
12
HELX_P
C
GLU
17
C
GLU
17
1
6
6
D
GLY
8
D
GLY
8
HELX_P
D
GLY
20
D
GLY
20
1
7
13
D
GLU
21
D
GLU
21
HELX_P
D
GLY
23
D
GLY
23
5
8
3
disulf
2.031
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.031
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.033
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
disulf
2.028
C
CYS
6
C
SG
CYS
6
1_555
C
CYS
11
C
SG
CYS
11
1_555
disulf
2.034
C
CYS
7
C
SG
CYS
7
1_555
D
CYS
7
D
SG
CYS
7
1_555
disulf
2.031
C
CYS
20
C
SG
CYS
20
1_555
D
CYS
19
D
SG
CYS
19
1_555
metalc
1.987
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
2_555
metalc
1.987
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
1_555
metalc
1.987
B
ZN
1031
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
3_555
metalc
1.899
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
1_555
metalc
1.899
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
2_555
metalc
1.899
B
ZN
1031
E
ZN
ZN
1_555
B
HOH
2025
K
O
HOH
3_555
metalc
2.016
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
1_555
metalc
2.016
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
2_555
metalc
2.016
D
ZN
1030
G
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
3_555
metalc
1.941
D
ZN
1031
H
ZN
ZN
1_555
D
GLU
13
D
OE1
GLU
13
1_555
metalc
2.138
D
ZN
1031
H
ZN
ZN
1_555
D
HOH
2017
M
O
HOH
1_555
metalc
2.006
D
ZN
1031
H
ZN
ZN
1_555
D
HOH
2016
M
O
HOH
1_555
metalc
2.498
D
ZN
1031
H
ZN
ZN
1_555
D
HIS
10
D
ND1
HIS
10
1_555
metalc
1.989
D
ZN
1032
I
ZN
ZN
1_555
D
HOH
2017
M
O
HOH
1_555
metalc
2.248
D
ZN
1032
I
ZN
ZN
1_555
D
GLU
13
D
OE2
GLU
13
1_555
HORMONE
CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, MICRO FOCUS BEAMLINE, INSULIN, HORMONE, SECRETED, MICRO CRYSTAL, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, DIABETES MELLITUS
INS_HUMAN
UNP
1
P01308
INS_HUMAN
UNP
2
P01308
90
110
2VK0
1
21
P01308
A
1
1
21
25
54
2VK0
1
30
P01308
B
2
1
30
90
110
2VK0
1
21
P01308
C
1
1
21
25
54
2VK0
1
30
P01308
D
2
1
30
2
anti-parallel
B
PHE
24
B
PHE
24
B
TYR
26
B
TYR
26
D
PHE
24
D
PHE
24
D
TYR
26
D
TYR
26
BINDING SITE FOR RESIDUE ZN D 1030
Software
3
BINDING SITE FOR RESIDUE ZN B 1031
Software
6
BINDING SITE FOR RESIDUE ZN D 1031
Software
7
BINDING SITE FOR RESIDUE ZN D 1032
Software
5
BINDING SITE FOR RESIDUE MPB C 1022
Software
7
D
HIS
10
D
HIS
10
3
2_555
D
HIS
10
D
HIS
10
3
1_555
D
HIS
10
D
HIS
10
3
3_555
B
HIS
10
B
HIS
10
6
2_555
B
HIS
10
B
HIS
10
6
1_555
B
HIS
10
B
HIS
10
6
3_555
B
HOH
2025
K
HOH
6
2_555
B
HOH
2025
K
HOH
6
3_555
B
HOH
2025
K
HOH
6
1_555
B
GLU
13
B
GLU
13
7
3_555
D
SER
9
D
SER
9
7
3_555
D
HIS
10
D
HIS
10
7
1_555
D
GLU
13
D
GLU
13
7
1_555
D
ZN
1032
I
ZN
7
1_555
D
HOH
2016
M
HOH
7
1_555
D
HOH
2017
M
HOH
7
1_555
B
GLU
13
B
GLU
13
5
3_555
D
GLU
13
D
GLU
13
5
3_555
D
GLU
13
D
GLU
13
5
1_555
D
ZN
1031
H
ZN
5
1_555
D
HOH
2017
M
HOH
5
1_555
A
LEU
13
A
LEU
13
7
3_555
A
TYR
14
A
TYR
14
7
3_555
A
GLU
17
A
GLU
17
7
3_555
B
VAL
18
B
VAL
18
7
3_555
C
TYR
14
C
TYR
14
7
1_555
C
GLU
17
C
GLU
17
7
1_555
D
VAL
18
D
VAL
18
7
1_555
146
H 3